▟ Vinebot intrinsic value, daily

← back

EMR Emerson Electric

industrial · valued with opus low conviction · deep-dived 2026-10-28

SELL
Intrinsic value$59.93
Price (at call)$166.27
Margin of safety -64.0%
vs market (rating basis) -35.9%

Good automation franchise, but at $166 the price assumes much more than durable mid-single-digit growth.

The story

Emerson is now a mostly pure-play automation franchise: process control systems, valves and measurement, test and measurement (NI), and industrial software (AspenTech). It has a large installed base and recurring software and service revenue, so it is a mature business that can grow modestly. The low reported sales-to-capital (0.55) comes from acquisition goodwill and says little about what new growth will cost. GAAP margins are held down by amortization of acquired intangibles, so they understate cash economics.

I raised target margin from 20% to 24% (20% relative). The TTM margin of 20.2% has already passed my old target, and acquired-intangible amortization of about 5-6% of revenue weighs on GAAP margins without reflecting how the business runs. I raised sales-to-capital from 1.4 to 2.0 because capex is about 2.4% of revenue, well below D&A, and the business is shifting toward software, so growth needs little new capital. I extended the horizon from 8 to 9 years. All three moves narrow a market gap that is still large on a heavily covered name; growth, terminal growth and beta stay unchanged.

Value drivers

Revenue growth (Y1)5.0%
Terminal growth2.8%
Forecast horizon9y
Target operating margin24.0%
Years to target margin4
Sales-to-capital2.00
Beta1.05
Failure probability0.5%
Cost of capital (WACC)9.2%
Terminal WACC9.0%

Valuation bridge

PV of explicit FCFF20.86B
PV of terminal value24.33B
Equity value33.43B
÷ shares → per share$59.93

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 19.23B 5.0% 21.1% 3.10B 457.90M 2.64B 2.42B
2 20.14B 4.7% 22.1% 3.39B 453.75M 2.94B 2.46B
3 21.03B 4.4% 23.0% 3.70B 446.84M 3.25B 2.49B
4 21.91B 4.2% 24.0% 4.01B 437.09M 3.57B 2.51B
5 22.76B 3.9% 24.0% 4.17B 424.45M 3.74B 2.41B
6 23.57B 3.6% 24.0% 4.32B 408.90M 3.91B 2.30B
7 24.35B 3.3% 24.0% 4.46B 390.44M 4.07B 2.19B
8 25.09B 3.0% 24.0% 4.59B 369.13M 4.22B 2.09B
9 25.78B 2.8% 24.0% 4.72B 345.03M 4.38B 1.98B

Key risks

  • Process-industry capex slows (chemicals, energy, discrete/test end markets), hitting orders
  • Integrating AspenTech and NI dilutes returns, or the premium paid erodes value
  • Leverage (about $11.6B net debt) limits flexibility if margins fall back toward 13-18%

Catalysts

  • Sustained 25%+ adjusted margins and software ARR growth that confirm the reshaped portfolio
  • Order recovery in test and measurement plus LNG, power and life-sciences project wins

History

DatePriceIntrinsicMoSRating
2026-10-28$166.27 $59.93 -64.0% SELL
2026-07-22$139.26 $47.57 -65.8% SELL
2026-07-21$136.58 $36.55 -73.2% N/A
2026-06-23$143.14 $55.06 -61.5% HOLD